Related Experiment Video

Updated: Jun 10, 2026

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

Microalbuminuria as a risk factor: the influence of renin-angiotensin system blockade

Jan Menne1, Christos Chatzikyrkou, Hermann Haller

  • 1Medizinische Hochschule, Hannover, Germany.

Journal of Hypertension
|July 17, 2010
PubMed

Insights

Microalbuminuria, an early sign of kidney damage, is linked to cardiovascular disease in diabetics and non-diabetics. Early detection and management are crucial for reducing heart risks.

Area of Science:

  • Nephrology
  • Cardiology
  • Endocrinology

Background:

  • Microalbuminuria (increased urinary albumin excretion) is traditionally linked to diabetic nephropathy.
  • Emerging evidence connects microalbuminuria to cardiovascular disease (CVD) risk in both diabetic and non-diabetic individuals, even at low levels.
  • This association highlights the systemic implications of early kidney dysfunction.

Purpose of the Study:

  • To review the link between microalbuminuria and cardiovascular disease.
  • To discuss the mechanisms underlying this association, including endothelial dysfunction and the renin-angiotensin system.
  • To emphasize the importance of screening and managing microalbuminuria for CVD risk reduction.

Main Methods:

  • Literature review of studies investigating microalbuminuria and cardiovascular outcomes.
  • Analysis of the role of the renin-angiotensin system and angiotensin II type 1 receptor in mediating vascular dysfunction.
  • Examination of the efficacy of ACE inhibitors and ARBs in managing microalbuminuria.

Main Results:

  • Microalbuminuria is a significant predictor of cardiovascular events in diverse populations.
  • Vascular and endothelial dysfunction, influenced by the renin-angiotensin system, likely mediates the increased CVD risk.
  • Pharmacological interventions targeting the renin-angiotensin system show promise in treating microalbuminuria.

Conclusions:

  • Microalbuminuria is an important marker for cardiovascular risk beyond diabetic kidney disease.
  • Screening for microalbuminuria in patients with hypertension and/or diabetes is recommended.
  • Interventions aimed at reducing microalbuminuria may contribute to lowering overall cardiovascular risk.

More Related Videos

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

Related Concept Videos

Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...